Autophagy in kidney homeostasis and disease
C Tang, MJ Livingston, Z Liu, Z Dong - Nature Reviews Nephrology, 2020 - nature.com
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic
components. Basal autophagy in kidney cells is essential for the maintenance of kidney …
components. Basal autophagy in kidney cells is essential for the maintenance of kidney …
Diabetes‐induced reactive oxygen species: mechanism of their generation and role in renal injury
S Fakhruddin, W Alanazi… - Journal of diabetes …, 2017 - Wiley Online Library
Diabetes induces the onset and progression of renal injury through causing hemodynamic
dysregulation along with abnormal morphological and functional nephron changes. The …
dysregulation along with abnormal morphological and functional nephron changes. The …
Everolimus with reduced calcineurin inhibitor exposure in renal transplantation
J Pascual, SP Berger, O Witzke… - Journal of the …, 2018 - journals.lww.com
Background Everolimus permits reduced calcineurin inhibitor (CNI) exposure, but the
efficacy and safety outcomes of this treatment after kidney transplant require confirmation …
efficacy and safety outcomes of this treatment after kidney transplant require confirmation …
Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy
A Tagawa, M Yasuda, S Kume, K Yamahara… - Diabetes, 2016 - Am Diabetes Assoc
Overcoming refractory massive proteinuria remains a clinical and research issue in diabetic
nephropathy. This study was designed to investigate the pathogenesis of massive …
nephropathy. This study was designed to investigate the pathogenesis of massive …
Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
D Yang, MJ Livingston, Z Liu, G Dong, M Zhang… - Cellular and Molecular …, 2018 - Springer
Diabetic kidney disease, a leading cause of end-stage renal disease, has become a serious
public health problem worldwide and lacks effective therapies. Autophagy is a highly …
public health problem worldwide and lacks effective therapies. Autophagy is a highly …
Mitochondrial dysfunction in the pathophysiology of renal diseases
R Che, Y Yuan, S Huang… - American Journal of …, 2014 - journals.physiology.org
Mitochondrial dysfunction has gained recognition as a contributing factor in many diseases.
The kidney is a kind of organ with high energy demand, rich in mitochondria. As such …
The kidney is a kind of organ with high energy demand, rich in mitochondria. As such …
Therapeutic inhibition of VEGF signaling and associated nephrotoxicities
CC Estrada, A Maldonado… - Journal of the American …, 2019 - journals.lww.com
Inhibition of vascular endothelial growth factor A (VEGFA)/vascular endothelial growth factor
receptor 2 (VEGFR2) signaling is a common therapeutic strategy in oncology, with new …
receptor 2 (VEGFR2) signaling is a common therapeutic strategy in oncology, with new …
Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation
LS Nguyen, M Vautier, Y Allenbach, N Zahr… - Drug safety, 2019 - Springer
Inhibitors of mechanistic target of rapamycin (mTOR inhibitors) are used as antiproliferative
immunosuppressive drugs and have many clinical applications in various drug …
immunosuppressive drugs and have many clinical applications in various drug …
[HTML][HTML] Strategies for the management of adverse events associated with mTOR inhibitors
B Kaplan, Y Qazi, JR Wellen - Transplantation reviews, 2014 - Elsevier
Mammalian target of rapamycin (mTOR) inhibitors are used as potent immunosuppressive
agents in solid-organ transplant recipients (everolimus and sirolimus) and as antineoplastic …
agents in solid-organ transplant recipients (everolimus and sirolimus) and as antineoplastic …